Jump to navigation

  • Cochrane Library
  • Cochrane.org
  • Admin
Home

Cochrane
Airways

Trusted evidence.
Informed decisions.
Better health.

Home

Do people with asthma have fewer serious adverse events when taking formoterol and inhaled corticosteroids compared to salmeterol and inhaled corticosteroids?

New Cochrane Review

Latest News and Events

Exercise training for bronchiectasis
News
Endothelin receptor antagonists for pulmonary arterial hypertension
News
Telerehabilitation for chronic respiratory disease
News
Pulmonary rehabilitation for interstitial lung disease Pulmonary rehabilitation for ILD: updated Cochrane Review
News
We are part of
Cochrane Circulation and Breathing

Tweets by CochraneAirways

Facebook logoTwitter logo

  • About us
    • People
    • About Cochrane
    • Cochrane Airways Australia
    • Scope of our work
    • Trials Register
    • Prioritising our work
    • Updating classification project
    • Respiratory guidelines
    • Funders and partners
    • Contact us
  • Our evidence
    • Our reviews
  • Resources
  • News
  • Join Cochrane
NIHR
See more information about funders
Cochrane
  • About Cochrane
    • Cochrane.org
    • Who we are
    • Get involved
    • Consumer Network
    • Partners
    • Colloquium
    • In the news
  • Publications
    • Cochrane Library
      • Library homepage
      • Cochrane Reviews (CDSR)
      • Trials (CENTRAL)
      • Cochrane Clinical Answers
    • Cochrane Library App
    • Journal Club
    • Podcasts
  • Community
    • Community
    • Archie log-in
    • Training and support
    • Methods
    • Software
    • Jobs and opportunities
    • Cochrane Store
  • Contact us
    • General enquiries
    • Cochrane Library support
    • Chief Executive Officer
    • Editor in Chief
    • Cochrane Groups
    • Media
RSS Twitter Facebook YouTube Instagram LinkedIn
Trusted evidence.
Informed decisions.
Better health.
Copyright © 2021 The Cochrane Collaboration
Disclaimer | Privacy | Cookie policy
We use cookies to improve your experience on our site. OK More information